Prenetics Global (PRE) EBITDA (2021 - 2026)

Prenetics Global has disclosed EBITDA across 6 years of filings, most recently posting -$365000.0 for Q1 2026.

• In Q1 2026, EBITDA fell 644.78% year-over-year to -$365000.0; the TTM figure through Mar 2026 stood at -$12.5 million (up 46.48% YoY), while the FY2025 annual figure was $486000.0, up 167.41% from the prior year.
• EBITDA advanced to -$365000.0 in Q1 2026, from -$1.1 million in the prior quarter.
• Over the last five years, EBITDA for PRE reached as high as $4.4 million in Q4 2022 and fell as low as -$148.4 million in Q2 2022.
• The 5-year median for EBITDA is -$11.6 million (2024), against an average of -$17.5 million.
• Annual changes were most pronounced in 2022 — EBITDA plunged 1853.6% — and 2025, when it jumped 115.58%.
• A 5-year view of EBITDA shows it stood at $4.4 million in 2022, then sank by 523.51% to -$18.5 million in 2023, then jumped by 97.71% to -$423000.0 in 2024, then slumped by 149.88% to -$1.1 million in 2025, then surged by 65.47% to -$365000.0 in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$365000.0, -$1.1 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.